Swiss company ‘Novartis’ acquires production facility to manufacture medicines in Pakistan

The company maintained substantial operational performance in Q1 FY 2020, with its net sales, grew by 13%.

2

A Swiss Multinational Company named Novartis has acquired a manufacturing facility to produce medicines in Pakistan.

In an official tweet, the Advisor to the Prime Minister on Trade and Investment, Abdul Razak Dawood, shared the news, saying, “Novartis, a Swiss MNC with a multi-decade presence in Pakistan, has acquired an industrial facility to produce medicines locally. The company has an expansion plan that will bring an investment of about $20 million in Pakistan.”

The Advisor also stated, “This investment signifies that the administrative reforms and competitive local landscape have been recognized as an opportunity by investors. This acquisition also shows the confidence of international companies to invest in the Pakistani Pharma industry. It highlights the progress of increased ease in doing business in Pakistan.”

It is pertinent to mention that the Swiss company maintained substantial operational performance in Q1 FY 2020, with its net sales, grew by 13%.

What are your views on this? Share in the comments bar below.

  • Great news ! Novartis is a major pharmaceutical company with great medicines specially for Hypertension and Diabetes. These two disease has major impact on Pakistani population, so I hope that Pakistanis would get good quality and low price drugs for these diseases in addition to employment/revenue generation opportunities.


  • Featured Content⭐


    Most viewed in last 24 hours


    24 گھنٹوں کے دوران 🔥


    >